News
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the MOBILIZE-1 ...
Merck initiates MOBILIZE-1 phase 3 study evaluating dengue vaccine candidate, V181: Rahway, New Jersey Friday, June 13, 2025, 11:00 Hrs [IST] Merck, known as MSD outside of the Un ...
Merck is establishing a program of clinical trials for V181, including conducting trials globally, in places where dengue is ...
As the nation prepares for National Mosquito Control Awareness Week (June 15–21), Mosquito Joe®, a Neighborly® company, is ...
A federal-regional-state partnership can significantly reduce response time, minimize logistical challenges and save lives ...
News-Medical.Net on MSN6d
Chikungunya vaccine could stop millions of infections worldwide, study findsA landmark global modeling study reveals that more than 2.8 billion people in 104 countries are at risk of chikungunya, with ...
The World Health Organization (WHO) Technical Advisory Group on Virus Evolution (TAG-VE) yesterday published a detailed risk ...
Detailed price information for Immunoprecise Antibodies Ltd (IPA-Q) from The Globe and Mail including charting and trades.
The Cool Down on MSN3d
Researchers raise red flag that doctors may be underprepared for devastating new disease emerging in US: 'We want to give the early warning'Babesiosis, a disease typically spread by blacklegged ticks, is on the rise in the mid-Atlantic, causing concern among ...
Department of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, 788 Petit Science Center, Atlanta, Georgia 30302, United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback